2021
Intraoperative Consultation
Buza N, Euscher E. Intraoperative Consultation. Practical Anatomic Pathology 2021, 317-343. DOI: 10.1007/978-3-030-68608-6_13.Peer-Reviewed Original ResearchFuture fertilityCommon differential diagnostic considerationsIntraoperative frozen section evaluationIntraoperative consultationExtent of surgeryFrozen section evaluationClinical differential diagnosisPatient's future fertilityPreoperative diagnostic workupDifferential diagnostic considerationsFrozen section laboratoryEndometrial cancerOvarian neoplasmsPelvic massCervical carcinomaDiagnostic workupGynecologic pathologyMalignant entitiesDiagnostic challengeSurgical specimensDiagnostic considerationsDifferential diagnosisPathology evaluationSurgical teamDisease type
2015
Intraductal papillary mucinous neoplasm (IPMN) with high-grade dysplasia is a risk factor for the subsequent development of pancreatic ductal adenocarcinoma
Rezaee N, Barbon C, Zaki A, He J, Salman B, Hruban RH, Cameron JL, Herman JM, Ahuja N, Lennon AM, Weiss MJ, Wood LD, Wolfgang CL. Intraductal papillary mucinous neoplasm (IPMN) with high-grade dysplasia is a risk factor for the subsequent development of pancreatic ductal adenocarcinoma. Hepato Pancreato Biliary 2015, 18: 236-246. PMID: 27017163, PMCID: PMC4814593, DOI: 10.1016/j.hpb.2015.10.010.Peer-Reviewed Original ResearchMeSH KeywordsAgedCarcinoma, Pancreatic DuctalDatabases, FactualDisease-Free SurvivalFemaleHumansKaplan-Meier EstimateLymphatic MetastasisMaleMiddle AgedNeoplasm GradingNeoplasm InvasivenessNeoplasms, Cystic, Mucinous, and SerousNeoplasms, Second PrimaryPancreatectomyPancreatic NeoplasmsProportional Hazards ModelsRisk AssessmentRisk FactorsTime FactorsTreatment OutcomeConceptsIntraductal papillary mucinous neoplasmHigh-grade dysplasiaPancreatic ductal adenocarcinomaNon-invasive intraductal papillary mucinous neoplasmsIntermediate-grade dysplasiaPapillary mucinous neoplasmRemnant pancreasVascular invasionMucinous neoplasmsDuctal adenocarcinomaInvasive pancreatic ductal adenocarcinomaMedian overall survivalLymph node metastasisRate of progressionSubsequent developmentIntermediate dysplasiaPancreatic resectionOverall survivalNode metastasisPerineural invasionMalignant entitiesRisk factorsPatientsDysplasiaPancreasTransvaginal Morcellation
Donat L, Clark M, Tower AM, Menderes G, Parkash V, Silasi DA, Azodi M. Transvaginal Morcellation. JSLS Journal Of The Society Of Laparoscopic & Robotic Surgeons 2015, 19: e2014.00255. PMID: 26005318, PMCID: PMC4432719, DOI: 10.4293/jsls.2014.00255.Peer-Reviewed Original ResearchConceptsTransvaginal morcellationLaparoscopic hysterectomyLeiomyomatous uterusUterine morcellationRobot-assisted laparoscopic hysterectomyLaparoscopic-assisted vaginal hysterectomyCharts of womenLarge uterine specimensMean uterine sizeMean blood lossRetrospective case seriesTotal laparoscopic hysterectomyWedge resection techniqueBaseline demographicsPostoperative outcomesSelect patientsSurgical complicationsBlood lossUterine sizeVaginal hysterectomyCase seriesOperative timeInstitution experienceMalignant entitiesMorcellation technique
2008
Imaging of Malignant Skeletal Tumors
Pahade J, Sekhar A, Shetty SK. Imaging of Malignant Skeletal Tumors. Cancer Treatment And Research 2008, 143: 367-422. PMID: 18619226, DOI: 10.1007/978-0-387-75587-8_15.Peer-Reviewed Original ResearchConceptsMagnetic resonance imagingPositron emission tomographyClinical featuresMalignant skeletal tumorsCommon malignant lesionKey imaging characteristicsSecondary neoplasmsBone scintigraphyPrimary lesionFinal diagnosisMalignant entitiesHistologic diagnosisSkeletal tumorsDifferential diagnosisMalignant tumorsEvidence-based foundationMalignant lesionsLesionsResonance imagingEmission tomographyImaging characteristicsPotential imaging modalityDiagnosisImaging modalitiesRecent evidence
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply